Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03585010 · ClinicalTrials.gov registry record · NA
Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT03585010: Completed NA study, sponsored by Yale University.
NCT03585010 is a NA study that has completed, run by Yale University. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03585010, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
This study aims to investigate whether a parent-based treatment for childhood anxiety disorders engages child brain circuitry implicated in children's reliance on parents to reduce anxiety (R61), and whether change in child brain circuitry is associated with reduction in child anxiety (R33).
Primary Outcome
The PARS is a clinician-administered measure of anxiety severity in children and adolescents. Total scores on PARS are used as indicator of anxiety severity. Total scores range from 0-35, with higher scores indicating more severe anxiety.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy
- BEHAVIORAL Parent Educational Support
- BEHAVIORAL Supportive Parenting for Anxious Childhood Emotions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2018-08-24 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
What the finished NCT03585010 record still lists
NCT03585010 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive-Behavioral Therapy is the first listed.
NCT03585010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03585010 about?
NCT03585010 is a clinical study titled "Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders". This study aims to investigate whether a parent-based treatment for childhood anxiety disorders engages child brain circuitry implicated in children's reliance on parents to reduce anxiety (R61), and whether change in child brain circuitry is associated with reduction in child anxiety (R33).
What is the current status of trial NCT03585010?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2018-08-24. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT03585010?
The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL), Parent Educational Support (BEHAVIORAL), Supportive Parenting for Anxious Childhood Emotions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03585010?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03585010's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI